FTD Testing Solutions for Respiratory Infections during 2022-23 Flu Season

The COVID-19 pandemic continues to be a serious global health threat. Testing for the detection of SARS-CoV-2 will remain critical for managing the pandemic even during flu season. The severity of the 2022-23 flu season is uncertain as it converges with the COVID-19 pandemic.

Click to play video

The detection and differentiation of respiratory pathogens is important for managing patients with acute respiratory syndromes. This is even more critical during the flu season as seasonal viruses can be life-threatening, especially for hospitalized immunocompromised patients. SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) have similar clinical presentations but require different treatment approaches. Therefore, early detection and differential diagnosis may be critical for optimal patient management.


Siemens Healthineers offers a flexible combination of respiratory testing solutions for your laboratories flu season testing needs during the COVID-19 pandemic and 2022-23 flu season

FTD SARS-CoV-2 Assay* for the specific detection of the coronavirus causing COVID-19

FTD SARS-CoV-2/FluA/FluB/HRSV Assay** for the detection and differentiation of SARS-CoV-2, IAV, IBV, and HRSV A/B

FTD FLU/HRSV Assay** for the detection of influenza A, influenza B, and human respiratory syncytial viruses A and B

FTD Respiratory pathogens 21 Assay** for the detection of 20 viruses and 1 bacterium

Features & Benefits

  • Clinically relevant kit configurations covering life-threatening circulating respiratory pathogens 
  • Robust assay designs showing excellent analytical and clinical performance
  • Flexible kit and workflow options allowing laboratories to manage comprehensive respiratory testing